What is FONR's health score?

FONAR CORP (FONR) has a TradeApes health score of 59 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is FONR's estimated fair value?

Based on our 5-year discounted cash flow model, FONAR CORP's estimated fair value is $12.24 per share, representing a -35.9% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is FONR undervalued or overvalued?

Our model currently rates FONR as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for FONR... Refresh in a moment for the full analysis.

FONAR CORP (FONR)

Healthcare Overvalued low mixed

$19.09

Updated: 2026-06-04

TradeApes Score

Financial Strength

75 Strong

Operating Trend

50 Mixed

Relative Value

50 Mixed

Capital Allocation

50 Mixed

Risk

80 Strong

Est. Fair Value $12.24

DCF Upside -35.9%

Sector Rank #524 of 6694

Key Findings

+ Strong interest coverage — EBIT covers interest 10×+

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.